Austedo is a brand-name prescription medication used to treat chorea associated with Huntington's disease and tardive dyskinesia [1].
What is the active ingredient in Austedo?
Austedo contains two active ingredients: deutetrabenazine [1]. Deutetrabenazine is a vesicular monoamine transporter 2 (VMAT2) inhibitor [1].
How does deutetrabenazine work?
Deutetrabenazine works by reducing the amount of a chemical messenger called dopamine in the brain [1]. By lowering dopamine levels, it can help control involuntary movements associated with Huntington's disease and tardive dyskinesia [1].
When does Austedo's patent expire?
Information regarding the specific patent expiration dates for Austedo is available through specialized databases that track drug patents. For detailed and up-to-date patent information, DrugPatentWatch.com is a valuable resource [2].
What are the potential side effects of Austedo?
Common side effects of Austedo can include drowsiness, fatigue, insomnia, dry mouth, nausea, and anxiety [1]. A serious potential side effect is depression and suicidal thoughts or behaviors [1]. Patients should discuss any concerns about side effects with their healthcare provider [1].
Are there alternatives to Austedo for Huntington's disease?
While Austedo is specifically indicated for chorea associated with Huntington's disease, other medications and therapeutic approaches may be considered depending on the patient's overall condition and specific symptoms [3]. Consulting with a neurologist or movement disorder specialist is crucial for determining the most appropriate treatment plan [3].
What is tardive dyskinesia?
Tardive dyskinesia is a neurological disorder that causes uncontrollable, repetitive body movements. It is often a side effect of long-term use of antipsychotic medications [1]. Austedo is one of the treatments available for this condition [1].
*
**Sources
1. https://www.austedo.com/
2. https://www.drugpatentwatch.com/
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886630/